NetworkNewsBreaks – Phivida Holdings Inc. (CSE:
Post# of 29
Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a hemp-cultivated cannabinoid innovator, applauded the recent elimination of cannabidiol (“CBD”) from the DEA’s Schedule 1 list of controlled substances. A recent article discussing the company reads, “Recently, Phivida Holdings talked about the removal of cannabidiol (CBD) from the U.S. Drug Enforcement Administration’s Schedule 1 list of controlled substances. In a news release, Jim Bailey, president and chief executive officer of Phivida, said, ‘We see this reclassification of CBD in pharmaceuticals as a good sign that will bolster the growing awareness of CBD as a substance that delivers many benefits, and opens the door for other CBD-based treatments, in line with the recent FDA approval of a drug to treat childhood epilepsy.’”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer